For the sporadically reported molecular parameters in tumors of NSND, such as immune response and checkpoint factors including the INFγ and NFKB pathways, larger studies are needed to confirm the value of these molecular parameters in cancer diagnosis, prognosis, individualized therapy selection, or therapy effect evaluation in NSND. This evidence concerns the gene NFKB1 and cancer.